MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence

    S. Zayed, S. Tabassum (Ranchi, India)

    Objective: To explore the association between anemia and the risk of Parkinson’s disease. Background: Parkinson’s disease (PD) is a common progressive neurodegenerative neurological disorder. More than…
  • 2024 International Congress

    Real-World Multicenter Analysis of Levodopa Equivalent Daily Dosage Algorithms- Capturing Geographical and Demographic Disparities in Parkinson’s Disease Therapy Spanning Six Countries and Two Continents

    P. Kukkle, L. Kalia, A. Habib, P. Jagota, R. Ojha, R. Kandadai, S. Desai, M. Caldera, D. Sirisena, D. Garg, T. Mestre, R. Neupane, S. Maytharakcheep, K. Sanyawut, R. Borgohain (Bangalore, India)

    Objective: To assess the influence of updated Levodopa Equivalent Daily Dosage (LEDD) conversion factors in capturing the newer therapies in Parkinson’s Disease (PD) and therapy…
  • 2024 International Congress

    Examination of how DaTscan Impacts Diagnosis in Parkinsonian Patients with and without Dopamine Receptor Blocking Agent Exposure

    R. Lopez-Castellanos, S. Factor, R. Blakes (Atlanta, USA)

    Objective: To determine whether Dopamine transporter imaging impacts diagnosis in parkinsonian patients Background: Dopamine transporter imaging (DaTscan) is a diagnostic tool used to assess loss…
  • 2024 International Congress

    A novel G413S mutation in the CSF1R gene causes Hereditary Diffuse Leucoencephalopathy with axonal Spheroids; clinically overlapping features of Parkinsonism

    ANW. Ullah, MZB. Badshah (Peshawar, Nepal)

    Objective: The current study was designed to investigate the genetic cause of atypical Parkinsonism is a multigenerational Pakistani family Background: Hereditary Diffuse Leucoencephalopathy with axonal…
  • 2024 International Congress

    Genome-wide Survival Analysis Identified Association Between HS1BP3 and APOE loci and Dementia in Parkinson’s disease

    S. Jo, J-H. Oh, J. Lee, S. Son, CO. Sung, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aim to conduct a genome-wide survival study (GWSS) to identify single nucleotide polymorphisms (SNP) associated with dementia in Parkinson’s disease (PD) with a…
  • 2024 International Congress

    Neuroprotective Action of Exogenous Melatonin in Parkinson Disease Patients and its Impact on Daily Routine: a Systematic Review

    G. Maia, P. Silva, M. Rosa, R. Albuquerque, E. Almeida, C. Menegon, V. Serafim, F. Oliveira, G. Sorato, I. Fink, C. Rieder (Porto Alegre, Brazil)

    Objective: This study aims to evaluate the neuroprotective action of exogenous melatonin in Parkinson disease patients and its impact on daily routine. Background: Parkinson Disease…
  • 2024 International Congress

    Clinical and neuroimaging factors associated with survival in Multiple System Atrophy

    G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

    Objective: To assess clinical and neuroimaging factors associated with survival in a cohort of patients with a final clinical diagnosis of Multiple System Atrophy (MSA)…
  • 2024 International Congress

    Assessing the Accuracy of Clinical Diagnostic Criteria of Lewy Body Dementia for Detection of Lewy Body Disease in the Oldest-Old: The 90+ Study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To examine if Lewy Body dementia (LBD) clinical diagnostic criteria will be less accurate for detecting Lewy Body Disease (the pathological diagnosis) in the oldest-old…
  • 2024 International Congress

    Peripheral immunity and clinical phenotypes in patients with ventriculomegaly

    C. Espinoza-Vinces, I. Avilés-Olmos, G. Martí-Andrés, M. Jiménez-Vázquez, M. Calvo-Imirizaldu, M. Marín Gracia, R. Villino-Rodríguez, A. Atorrasagasti-Villar, J. Arbizu, MR. Luquin (PAMPLONA, Spain)

    Objective: To characterize the neutrophil-to-lymphocyte ratio (NLR) levels in the peripheral blood of patients with ventriculomegaly and its correlation with clinical outcomes Background: Ventriculomegaly is…
  • 2024 International Congress

    Delayed Parkinsonism as a Delayed Neurological Sequele in Carbon Monoxide Intoxication: A Rare Case Report

    CP. Gasmara, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)

    Objective: To report delayed onset parkinsonism in carbon monoxide intoxication. Background: Secondary parkinsonism as a delayed neurological sequel (DNS) after gas or chemical substance exposure…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley